Bosutinib

Bosutinib is a second-generation BCR-ABL tyrosine kinase inhibitor used for chronic myeloid leukaemia, including cases resistant or intolerant to earlier-generation therapies. Simson Pharma's Bosutinib reference standard and impurities support stability-indicating method development for this targeted oncology agent.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Bosutinib Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Bosutinib
Bosutinib Impurity 8
Bosutinib Didesmethyl TriHydrochloride Impurity
2,4-Dichloro-5-methoxyaniline
Bosutinib N-oxide
N-Desmethyl Bosutinib
Bosutinib 4-Chloro 7-Chloropropoxy Impurity
Bosutinib Impurity 8
Bosutinib 4-Hydroxy 7-Chloropropoxy Impurity
Bosutinib Chloro Impurity
4-(2,4-Dichloro-5-methoxyphenylamino)-7-hydroxy-6-methoxyquinoline-3-carbonitrile
4-(2,4-Dichloro-5-methoxyphenylamino)-6,7-dimethoxyquinoline-3-carbonitrile
Bosutinib (Form-R)
Bosutinib Desmethyl Impurity
Bosutinib dimer impurity
Bosutinib Regio isomer impurity
Bosutinib Monohydrate
Bosutinib Didesmethyl Impurity
7-(3-Chloropropoxy)-6-methoxy-4-(4-methyl piperazin-1-yl)quinolone-3-carbonitrile
Bosutinib Nitroso Impurity
7-(3-Chloropropoxy)-4-((2,4-dichloro-5-methoxyphenyl)nitrosoamino)-6-methoxyquinoline-3-carbonitrile
Bosutinib Impurity II
Bosutinib Des NMP Impurity
N-Nitroso N-Desmethyl Bosutinib
N-Nitroso Bosutinib Impurity II
Bosutinib Impurity 31
Bosutinib Impurity 12
Bosutinib Dimer Impurity 2
Bosutinib Impurity 13
Bosutinib Propoxy Dimer Impurity
Bosutinib N-Oxide Impurity 2
Bosutinib N-Oxide Impurity 3
Bosutinib Impurity 2
Bosutinib Impurity 3
Bosutinib Impurity 4
Bosutinib Impurity 5
Bosutinib Impurity 6
Bosutinib Impurity 7
Bosutinib Impurity 1
Brigatinib Impurity 4

Isotope Labelled Compounds

Bosutinib D8
Bosutinib D9